Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

POLOXAMER 237 CRS (100 MG)

POLOXAMER 237 CRS (100 MG)

06/11/9003

DISCOVER
POLOXAMER 338 CRS (100 MG)

POLOXAMER 338 CRS (100 MG)

06/11/9003

DISCOVER
POLOXAMER 407 CRS (100 MG)

POLOXAMER 407 CRS (100 MG)

06/11/9003

DISCOVER
POLYACRYLATE - REFERENCE SPECTRUM (N/A)

POLYACRYLATE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
Pregabalin

Pregabalin

148553-50-8

DISCOVER
POLYMYXIN B SULFATE CRS (26.62 MG)

POLYMYXIN B SULFATE CRS (26.62 MG)

1405-20-5

DISCOVER
POLY(VINYL CHLORIDE) CRS (100MG)

POLY(VINYL CHLORIDE) CRS (100MG)

9002-86-2

DISCOVER
Prazepam

Prazepam

2955-38-6

DISCOVER
POTASSIUM CLAVULANATE - REFERENCE SPECTRUM (N/A)

POTASSIUM CLAVULANATE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
POTASSIUM SORBATE CRS (25 MG)

POTASSIUM SORBATE CRS (25 MG)

590-00-1

DISCOVER
POVIDONE CRS (50 MG)

POVIDONE CRS (50 MG)

9003-39-8

DISCOVER
PRAZEPAM CRS - * PSY (15 MG)

PRAZEPAM CRS - * PSY (15 MG)

2955-38-6

DISCOVER